AP NEWS

Global Diabetes Therapeutics Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 16% - ResearchAndMarkets.com

June 12, 2018

DUBLIN--(BUSINESS WIRE)--Jun 12, 2018--The “Diabetes Therapeutics Market by Product [Injectables] - Global Opportunity Analysis and Industry Forecast, 2017-2023” report has been added to ResearchAndMarkets.com’s offering.

The global diabetes therapeutics market was valued at $66,993 million in 2016, and is estimated to reach $186,842 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. Diabetes therapeutics are drugs used by diabetic patients to restore the blood glucose metabolism to a normal state.

The factors that drive the global diabetes therapeutics market include rise in geriatric population, increase in prevalence of diabetes worldwide, sedentary lifestyle of people, development of affordable & effective diabetes therapeutics, growth in awareness among people about self-management of diabetes, and support from the government However, side effects of diabetic drugs and stringent approval process for the same restrict the market growth. Moreover, surge in awareness about diabetes care and market potential in developing regions are expected to provide numerous opportunities for market growth.

The global diabetes therapeutics market is segmented on the basis of product and region. Based on product, it is bifurcated into injectable and oral-antidiabetic drugs (OAD). Injectable are further categorized into insulin, glucagon-like peptide-1 (GLP-1) receptor agonists, and amylinomimetic drug. Oral-antidiabetic drugs (OAD) segment is further divided into biguanides, sulfonylureas, thiazolidinediones, alpha-glucosidase inhibitors, dipeptidyl peptidase IV (DPP-4) inhibitors, meglitinides, and sodium-glucose cotransporter-2 (SGLT2) inhibitors.

Companies Mentioned:

AstraZeneca plc Boehringer Ingelheim GmbH Eli Lilly and Company GlaxoSmithKline plc Johnson & Johnson Merck & Co., Inc. Novartis AG Novo Nordisk Sanofi S.A. Takeda Pharmaceutical Company Limited Astellas Pharma Inc. Biocon Limited Diasome Pharmaceuticals, Inc. Generex Biotechnology Corp. MannKind Corporation Pfizer Inc.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Global Diabetes Therapeutics Market, By Product

Chapter 5 Diabetes Therapeutics Market, By Region

Chapter 6 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/5c7wks/global_diabetes?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180612005743/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infusions and Injectables ,Endocrine and Metabolic Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY DIABETES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/12/2018 06:52 AM/DISC: 06/12/2018 06:52 AM

http://www.businesswire.com/news/home/20180612005743/en

AP RADIO
Update hourly